The MAFENIDE ACETATE CREAM is a the manufacturer industrial component. Key specifications include administration: TOPICAL, primary_container_type: JAR, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_ingredient_and_strength: 8.500 MAFENIDE PERCENTAGE, W/W, primary_container_content_quantity: 16.000 OUNCES OZ, part_name_assigned_by_controlling_agency: MAFENIDE ACETATE CREAM 8.5% SULFAMYLON TOPICAL JAR 16OZ OZ. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-561-6429, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | TOPICAL |
| primary_container_type | JAR |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_ingredient_and_strength | 8.500 MAFENIDE PERCENTAGE, W/W |
| primary_container_content_quantity | 16.000 OUNCES OZ |
| part_name_assigned_by_controlling_agency | MAFENIDE ACETATE CREAM 8.5% SULFAMYLON TOPICAL JAR 16OZ OZ |
| NSN | 6505-01-561-6429 |
| PRIMARY CONTAINER TYPE | JAR |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MAFENIDE ACETATE CREAM 8.5% SULFAMYLON TOPICAL JAR 16OZ OZ |
| ACTIVE INGREDIENT AND STRENGTH | 8.500 MAFENIDE PERCENTAGE, W/W |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | 8.5% MAFENIDE ACTIVE INGREDIENT; NONSTAINING; WATER-VISCIBLE; ANTI-INFECTIVE CREAM FOR TOPICAL ADMINISTRATION TO BURN WOUNDS AND IS INDICATED FOR ADJUNCTIVE THERAPY OF PATIENTS WITH SECOND-AND THIRD-DEGREE BURNS; AVOID EXPOSURE TO EXCESSIVE HEAT (40 DEG.C OR ABOVE); 16 OZ. PLASTIC JAR OZ |
| PRIMARY CONTAINER CONTENT QUANTITY | 16.000 OUNCES OZ |
| ADMINISTRATION | TOPICAL |